China National Chemical Corporation

Text (OCR of the scan at left; may contain errors)

IN THE MATTER OF CHINA NATIONAL CHEMICAL CORPORATION, ADAMA AGRICULTURAL SOLUTIONS LTD., AND MAKHTESHIM AGAN OF NORTH AMERICA, INC. D/B/A ADAMA Docket No. C-4610. Order, September 26, 2017 Letter notifying China National Chemical Corporation of the Commission’s decision to waive prior approval and public comment regarding modifications to the formulation services agreement. LETTER WAIVING PRIOR APPROVAL AND COMMENT FOR MODIFICATIONS TO AN AGREEMENT Peter Guryan, Esq.

Simpson Thacher & Bartlett LLP Re: In the Matter of China National Chemical Corporation, et al., Docket No. C-4610 Dear Mr. Guryan:

This is in reference to an application for approval of a modification filed by China National Chemical Corporation (“ChemChina”) and received on September 14, 2017 (“Application”). Pursuant to the Decision and Order in Docket No. C-4610, ChemChina requests Commission approval of its proposal to modify the formulation services agreement between Makhteshim Agan of North America, Inc. (a subsidiary of ChemChina) and Amvac Chemical Corporation. After consideration ofChemChina’s Application and pursuant to the authority delegated to me under Rule 2.41(t)(5)(ii) of the Commission’s Rules of Practice, 16 C.F.R. § 2.41(t)(5)(ii), I hereby waive the requirements for Commission approval and the public comment period for the modifications to the formulation services agreement described in ChemChina’s Application. CHINA NATIONAL CHEMICAL CORPORATION 1067 Interlocutory Orders, Etc.

If you have further questions, please contact Jeff Dahnke, the Compliance staff attorney assigned to this matter. Mr. Dahnke can be reached at 202-326-2111 or [email protected]. Very truly yours, VOLUME 164 Interlocutory Orders, Etc.